KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angi (ANGI) Cash & Equivalents (2016 - 2025)

Angi (ANGI) has disclosed Cash & Equivalents for 10 consecutive years, with $303.7 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 27.07% to $303.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $303.7 million through Dec 2025, down 27.07% year-over-year, with the annual reading at $303.7 million for FY2025, 27.07% down from the prior year.
  • Cash & Equivalents hit $303.7 million in Q4 2025 for Angi, down from $340.7 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $777.0 million in Q1 2021 to a low of $303.7 million in Q4 2025.
  • Historically, Cash & Equivalents has averaged $401.9 million across 5 years, with a median of $368.7 million in 2023.
  • Biggest five-year swings in Cash & Equivalents: surged 102.23% in 2021 and later crashed 49.64% in 2022.
  • Year by year, Cash & Equivalents stood at $428.1 million in 2021, then decreased by 24.99% to $321.2 million in 2022, then grew by 13.35% to $364.0 million in 2023, then grew by 14.39% to $416.4 million in 2024, then decreased by 27.07% to $303.7 million in 2025.
  • Business Quant data shows Cash & Equivalents for ANGI at $303.7 million in Q4 2025, $340.7 million in Q3 2025, and $362.5 million in Q2 2025.